Literature DB >> 12119997

Sleep disordered breathing--a new component of syndrome x?

S Coughlin1, P Calverley, J Wilding.   

Abstract

Sleep disordered breathing (SDB) is a complication of obesity estimated to occur in about 4-6% of overweight individuals. These respiratory disturbances during sleep incorporate a number of conditions including snoring, upper airway resistance syndrome and obstructive sleep apnoea syndrome (OSAS). It is thought that as well as having deleterious effects on sleep quality these conditions may also promote cardiovascular and hormonal changes leading to an elevated blood pressure and an increased incidence of cardiovascular morbidity. Evidence reviewed here points to an alteration in sympathovagal balance, baroreceptor sensitivity, insulin resistance and leptin, growth hormone and lipid levels. Whether these changes are a consequence of the associated obesity or the SDB itself remains to be proven.

Entities:  

Mesh:

Year:  2001        PMID: 12119997     DOI: 10.1046/j.1467-789x.2001.00045.x

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  12 in total

1.  Metabolic syndrome and sleep apnea.

Authors:  I Kostoglou-Athanassiou; P Athanassiou
Journal:  Hippokratia       Date:  2008-04       Impact factor: 0.471

2.  Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation?

Authors:  R Nisha Aurora; Naresh M Punjabi
Journal:  Sleep Med Clin       Date:  2007-06-01

3.  Increased neck soft tissue mass and worsening of obstructive sleep apnea after growth hormone treatment in men with abdominal obesity.

Authors:  Mahssa Karimi; Josef Koranyi; Celina Franco; Yüksel Peker; Derek N Eder; Jan-Erik Angelhed; Lars Lönn; Ludger Grote; Bengt-Ake Bengtsson; Johan Svensson; Jan Hedner; Gudmundur Johannsson
Journal:  J Clin Sleep Med       Date:  2010-06-15       Impact factor: 4.062

4.  Level of proinsulin in association with cardiovascular risk factors and sleep snoring.

Authors:  En-Zhi Jia; Zhi-Jian Yang; Shi-Wei Chen; Guang-Yao Qi; Chun-Fa You; Jian-Feng Ma; Jing-Xin Zhang; Zhen-Zhen Wang; Wei-Chong Qian; Hai-Yan Wang; Wen-Zhu Ma
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

5.  Uvulopalatopharyngoplasty with an ultrasound scalpel or laser: is there a difference?

Authors:  Perttu Reijo Juhani Halme; J Antila; H Antila; H Aho; O Polo; H Salminiitty; E Toskala
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-16       Impact factor: 2.503

6.  Metabolic syndrome is directly associated with gamma glutamyl transpeptidase elevation in Japanese women.

Authors:  Hiroshi Sakugawa; Tomofumi Nakayoshi; Kasen Kobashigawa; Hiroki Nakasone; Yuko Kawakami; Tsuyoshi Yamashiro; Tatsuji Maeshiro; Ko Tomimori; Satoru Miyagi; Fukunori Kinjo; Atsushi Saito
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

7.  Fixed-pressure nCPAP in patients with obstructive sleep apnea (OSA) syndrome and chronic obstructive pulmonary disease (COPD): a 24-month follow-up study.

Authors:  Domenico Maurizio Toraldo; Francesco De Nuccio; Giuseppe Nicolardi
Journal:  Sleep Breath       Date:  2009-09-13       Impact factor: 2.816

8.  Sleep disordered breathing and metabolic syndrome.

Authors:  F Javier Nieto; Paul E Peppard; Terry B Young
Journal:  WMJ       Date:  2009-08

9.  Chronic intermittent hypoxia sensitizes acute hypothalamic-pituitary-adrenal stress reactivity and Fos induction in the rat locus coeruleus in response to subsequent immobilization stress.

Authors:  S Ma; S W Mifflin; J T Cunningham; D A Morilak
Journal:  Neuroscience       Date:  2008-05-06       Impact factor: 3.590

10.  Prevalence and severity of syndrome Z in women with metabolic syndrome on waiting list for bariatric surgery: a cross-sectional study.

Authors:  Eduardo Araujo Perez; Luis Vicente Franco Oliveira; Wilson Rodrigues Freitas; Carlos Alberto Malheiros; Elias Jirjoss Ilias; Anderson Soares Silva; Jessica Julioti Urbano; Patricia Clemente Oliveira; Felipe X Cepeda; Luciana M M Sampaio; Ivani C Trombetta; Humberto Delle; Daniel Gianella Neto; Sergio Roberto Nacif; Roberto Stirbulov
Journal:  Diabetol Metab Syndr       Date:  2017-09-20       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.